Keratitis sicca (dry eye disease) - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Keratitis Sicca (Dry Eye Disease) – Comprehensive Medical Guide

Keratitis Sicca (Dry Eye Disease)

Overview

Keratitis sicca, more commonly known as dry eye disease (DED), is a chronic, multifactorial disorder of the ocular surface characterized by insufficient tear production, excessive tear evaporation, or an abnormal tear film composition. The condition leads to ocular surface inflammation, damage to the cornea and conjunctiva, and a wide range of uncomfortable symptoms.

DED can affect anyone, but it is most prevalent among:

  • Women, especially after menopause (up to 2‑3× higher risk than men)
  • People over the age of 50 (prevalence rises from ~5% in those <40 y to >30% in those >70 y) [1]
  • Contact‑lens wearers
  • Individuals with autoimmune disorders such as Sjögren’s syndrome, rheumatoid arthritis, or lupus
  • Patients who spend many hours in air‑conditioned or heated environments, or who use digital screens for prolonged periods

Globally, dry eye disease affects an estimated 5–30 % of the adult population, making it one of the most common ocular surface disorders worldwide [2].

Symptoms

The clinical presentation of keratitis sicca can be highly variable. Patients often experience a combination of the following symptoms, which may fluctuate throughout the day:

  • Burning or stinging sensation – a feeling similar to having a foreign body in the eye.
  • Foreign‑body sensation – the persistent impression that something is in the eye.
  • Eye redness (hyperemia) – superficial blood vessel dilation.
  • Blurred vision – often improves with blinking.
  • Excessive tearing (reflex tearing) – paradoxically, irritation can trigger lacrimal overflow.
  • Photophobia – increased sensitivity to light.
  • Itching or mild pain.
  • Sticky or stringy discharge – especially in the mornings.
  • Difficulty wearing contact lenses – intolerance or frequent drop‑outs.
  • Fluctuating visual acuity – especially after reading or using a computer.

Symptoms often worsen in low‑humidity environments, after prolonged screen use, or upon waking after a night of reduced tear production.

Causes and Risk Factors

Dry eye disease results from an imbalance between the tear‑film aqueous, mucin, and lipid layers. The principal mechanisms include:

1. Decreased Tear Production (Aqueous‑Deficient Dry Eye)

  • Age‑related lacrimal gland atrophy.
  • Autoimmune diseases (e.g., Sjögren’s syndrome, rheumatoid arthritis).
  • Medications that reduce tear secretion: antihistamines, antidepressants, beta‑blockers, isotretinoin, diuretics.
  • Radiation therapy or ocular surgery that damages lacrimal glands.

2. Increased Tear Evaporation (Evaporative Dry Eye)

  • Meibomian gland dysfunction (MGD) – the most common cause of evaporative DED.
  • Contact lens wear – disrupts lipid layer and increases evaporation.
  • Environmental exposure: wind, low humidity, air‑conditioned or heated rooms.
  • Eyelid abnormalities: blepharitis, incomplete blink, entropion/ectropion.

3. Tear Film Instability

  • Altered mucin production (from goblet cells) due to inflammation.
  • Allergic conjunctivitis or ocular surface disease.

Risk Factors Summary

  • Female gender, especially post‑menopause.
  • Age >50 years.
  • Systemic autoimmune disease.
  • Medications that depress tear secretion.
  • High‑intensity screen usage (>4 hours/day).
  • Environmental extremes (dry, windy, smoky).
  • Prior ocular surgery (LASIK, cataract extraction).

Diagnosis

Diagnosing keratitis sicca involves a structured history, symptom scoring, and objective clinical tests.

1. Patient‑Reported Questionnaires

  • Ocular Surface Disease Index (OSDI) – scores severity from 0–100.
  • Dry Eye Questionnaire (DEQ‑5) – quick screening tool.

2. Clinical Examination

  • Slit‑lamp biomicroscopy to assess tear meniscus, conjunctival redness, and corneal staining.
  • Evaluation of lid margin for meibomian gland disease or blepharitis.

3. Objective Tests

  • Schirmer I Test (without anesthesia): strips placed at the lower lid for 5 minutes; <10 mm indicates aqueous deficiency.
  • Tear Break‑up Time (TBUT): fluorescein dye used; <10 seconds suggests tear‑film instability.
  • Osmolarity Measurement (tear‑film osmometer): values >308 mOsm/L are diagnostic of DED.
  • Lipid‑layer interferometry (e.g., LipiView®) to quantify meibomian gland function.
  • Meibography – infrared imaging to visualize meibomian gland dropout.
  • Inflammatory markers (MMP‑9 point‑of‑care test – InflammaDry®) to detect ocular surface inflammation.

4. Differential Diagnosis

Conditions that can mimic or coexist with dry eye include allergic conjunctivitis, conjunctival infections, ocular rosacea, and neuropathic pain syndromes. A thorough work‑up helps rule out these alternatives.

Treatment Options

Treatment is individualized, aiming to restore tear‑film homeostasis, control inflammation, and address underlying risk factors. Management typically follows a step‑ladder approach.

1. Lifestyle Modifications

  • Increase ambient humidity (humidifiers).
  • Take regular “20‑20‑20” breaks during screen use.
  • Avoid direct airflow from fans, air‑conditioners, or car vents.
  • Wear wrap‑around sunglasses outdoors to reduce evaporation.
  • Stay hydrated – ≥2 L of water daily.

2. Over‑the‑Counter (OTC) Eye Drops

  • Artificial tears – preservative‑free, sodium hyaluronate, or carboxymethylcellulose formulations; used 4–6 times daily.
  • Lubricating ointments or gels – applied at night for prolonged coverage.

3. Prescription Medications

  • Ciclosporin A 0.05 % (Restasis®) – immunomodulatory; improves tear production after 3–6 months.
  • Lifitegrast 5 % (Xiidra®) – blocks LFA‑1/ICAM‑1 interaction, reducing inflammation.
  • Topical corticosteroids (short‑term) – for acute flare‑ups; tapering schedule essential to avoid cataract or glaucoma.
  • Oral tetracyclines (doxycycline 40 mg daily) – anti‑inflammatory effect on meibomian glands.
  • Autologous serum eye drops – for severe refractory cases; contains growth factors that promote epithelial healing.

4. Procedural Interventions

  • Punctal plugs (silicone or collagen) – occlude tear drainage to retain moisture.
  • Meibomian gland expression (thermal or manual) – improves lipid layer quality.
  • Intense Pulsed Light (IPL) therapy – reduces abnormal vessels and meibomian gland inflammation.
  • Thermal pulsation (e.g., LipiFlow®) – delivers controlled heat & massage to restore gland function.
  • Amniotic membrane transplantation – reserved for severe ulcerative keratitis.

5. Emerging Therapies

  • Biologic agents targeting specific inflammatory pathways (e.g., anti‑IL‑17, anti‑TNFα) – under clinical investigation.
  • Nanoparticle‑based lubricants delivering longer‑lasting hydration.

Living with Keratitis sicca (dry eye disease)

Successful long‑term management requires daily habits that support tear‑film health.

  • Follow a regular lubrication schedule – keep a bottle of preservative‑free artificial tears at work, home, and in your bag.
  • Warm compresses – 5‑10 minutes, twice daily, followed by gentle eyelid massage to express meibomian glands.
  • Eye hygiene – clean eyelid margins with diluted baby shampoo or commercial lid‑scrub wipes.
  • Nutrition – omega‑3 fatty acids (e.g., fish oil, flaxseed) have modest benefit; aim for 1–2 g EPA/DHA per day per NHS guidance.
  • Screen ergonomics – position monitor at eye level, use anti‑glare screens, and blink consciously.
  • Avoid smoke and pollutants – both exacerbate tear evaporation.
  • Regular follow‑up – schedule eye examinations every 6–12 months, or sooner if symptoms change.

Prevention

While some risk factors (age, genetics) cannot be altered, many preventive steps can reduce the likelihood of developing or worsening dry eye:

  • Maintain optimal indoor humidity (30–50 %).
  • Limit exposure to direct wind or air‑conditioning drafts.
  • Take scheduled breaks during prolonged visual tasks (20‑second blink exercises every 20 minutes).
  • Stay hydrated and consume a balanced diet rich in omega‑3 fatty acids.
  • Manage systemic conditions (e.g., diabetes, rheumatoid arthritis) with your primary physician.
  • Discuss medication side‑effects with your healthcare provider—consider alternatives if you experience dry eye.
  • Regularly clean contact lenses and replace them as recommended.

Complications

If left untreated, chronic keratitis sicca can lead to serious ocular sequelae:

  • Corneal epithelial erosions – painful breaks in the surface that increase infection risk.
  • Corneal ulceration or infiltrates – may threaten vision.
  • Scarring (neovascularization) and reduced visual acuity.
  • Increased susceptibility to bacterial, viral, or fungal keratitis.
  • Persistent ocular surface inflammation – can cause secondary glaucoma due to steroid use.
  • Reduced quality of life – chronic discomfort, reading difficulty, and work productivity loss.

When to Seek Emergency Care

Call emergency services or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe eye pain or a deep, aching sensation.
  • Sudden loss of vision or a rapid decline in visual clarity.
  • Sudden increase in redness accompanied by a thick yellow/green discharge (possible infection).
  • Photophobia with a feeling of a foreign body that does not improve with blinking.
  • Corneal ulcer or white spot on the cornea visible on exam.
  • Swelling of the eyelids or face, especially if associated with fever.
Prompt evaluation can prevent permanent damage and preserve vision.

References

  1. American Academy of Ophthalmology. Dry Eye Syndrome. AAO Preferred Practice Pattern. 2023.
  2. Wolffsohn JS, et al. Prevalence of dry eye disease: A systematic review. Ophthalmology. 2022;129(3):294‑305.
  3. Mayo Clinic. Dry eye. https://www.mayoclinic.org. Accessed May 2026.
  4. Cleveland Clinic. Dry Eye Disease: Symptoms, Diagnosis & Treatment. https://my.clevelandclinic.org. Accessed May 2026.
  5. National Eye Institute. Facts About Dry Eye. NIH, 2024. https://www.nei.nih.gov.
  6. World Health Organization. Global Burden of Visual Impairment. 2023 report.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References